MEDICAL MARIJUANA, INC. HOME

More:   CANNABIS NEWS      INVESTORS     SHOP     CONTACT

  • About Us
    • About Us
    • A Company of Firsts
    • Industry Overview
    • Careers
    • Investors
  • Shop
    • CBD Oil
    • CBD Tinctures
    • CBD Capsules
  • News
    • Company News
    • Media Coverage
  • CBD Oil 101
    • CBD Oil: The Basics
    • Shop CBD Oil
    • CBD Oil FAQs
    • Is CBD Psychoactive
    • Is it Safe to Use CBD Oil?
    • Is Cannabidiol Legal?
    • CBD Sevings: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • Vaping 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • About Us
    • About Us
    • A Company of Firsts
    • Industry Overview
    • Careers
    • Investors
  • Shop
    • CBD Oil
    • CBD Tinctures
    • CBD Capsules
  • News
    • Company News
    • Media Coverage
  • CBD Oil 101
    • CBD Oil: The Basics
    • Shop CBD Oil
    • CBD Oil FAQs
    • Is CBD Psychoactive
    • Is it Safe to Use CBD Oil?
    • Is Cannabidiol Legal?
    • CBD Sevings: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • Vaping 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague

by Kyle Porter | Mar 1, 2022 | HempMeds Brasil, Press Releases

SAN DIEGO, CA, March 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium

by Kyle Porter | Feb 24, 2022 | HempMeds Brasil, Press Releases

SAN DIEGO, CA, Feb. 24, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical...
Medical Marijuana, Inc. Subsidiaries Record Biggest Sales Month Ever in July

Medical Marijuana, Inc. Subsidiaries Record Biggest Sales Month Ever in July

by Moises | Aug 8, 2019 | Company News, HempMeds, HempMeds Brasil, HempMeds Mexico

HempMeds® and subsidiaries HempMeds® Brasil ands HempMeds® Mexico all reached sales milestones last month distributing our top quality hemp CBD brands.  Medical Marijuana, Inc. portfolio company HempMeds® and its subsidiaries HempMeds® Brasil and HempMeds® Mexico...
Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

by Moises | May 22, 2019 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, Kannaway

Important achievements from across our portfolio of companies helped drive record revenue and continued success in the opening months of 2019. Medical Marijuana, Inc. and our portfolio of companies and investments continued our upward trend in the first fiscal quarter...
HempMeds® Brasil Invites Doctors to U.S. Offices for Educational Symposium

HempMeds® Brasil Invites Doctors to U.S. Offices for Educational Symposium

by Moises | May 10, 2019 | Company News, HempMeds Brasil

The first company to legally ship CBD products to Brazil, subsidiary HempMeds® Brasil continues its series of educational CBD symposiums for doctors with event in hometown. Medical Marijuana, Inc. subsidiary HempMeds® Brasil hosted an International Symposium on...
How Medical Marijuana, Inc. Worked to Advance the Cannabis Industry in the Past Year

How Medical Marijuana, Inc. Worked to Advance the Cannabis Industry in the Past Year

by Moises | Apr 19, 2019 | Axim Biotechnologies, Company News, Dixie Botanicals, HempMeds, HempMeds Brasil, Kannaway, Real Scientific Hemp Oil

This 4/20, we look at how our family of companies have helped to support the cannabis industry, consumers, and patients around the world. The cannabis industry and cannabis enthusiasts pause this 4/20 to celebrate all things cannabis, including the rapid expansion of...
« Older Entries

Latest News

  • Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes
  • Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
  • Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study
  • Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company
  • Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Direct Sales Veteran Eric Glenn as Entrepreneur

POPULAR

  • CBD Edibles Guide: Benefits, Uses and Buying Options
  • CBD Extract Oil: What to Know Before Buying
  • How to Use CBD Oil: 7 Easy Ways to Get Started with CBD
  • CBD Isolate Effects: Understanding Its Uses and Effects on the Body
  • What is CBDA? Everything You Need to Know About CBDA vs CBD

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Investors     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.